Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer
GLEN ALLEN, Va., Nov. 05, 2024 ( GLOBE NEWSWIRE ) -- Adial Pharmaceuticals, Inc. ( NASDAQ: ADIL ) ( "Adial" or the "Company" ) , a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced the ...
| Ticker |
Sentiment |
Impact |
|
ADIL
|
Somewhat Bullish
|
18 %
|
|
VRPX
|
Neutral
|
7 %
|
|
CAH
|
Neutral
|
4 %
|
